Mystical experiences during magnesium-Ibogaine are associated with improvements in PTSD symptoms in veterans.
Journal of affective disorders November 18, 2025 Randi Brown, Jennifer Lissemore, Kenneth Shinozuka et al. 1 citation
Among 30 male Veterans with traumatic brain injury from repeated blast/combat exposures, those who reported more intense mystical experiences during magnesium-ibogaine therapy showed larger reductions in PTSD severity both immediately and one month after treatment. Greater mystical experience intensity was also linked to larger reductions in peak alpha frequency one month later. The findings suggest that mystical experiences may contribute to improvements in PTSD following magnesium-ibogaine and may relate to persisting decreases in peak alpha frequency.